The authors also used quantitative reverse transcription polymerase chain reaction to evaluate ER tumor expression and reported that ERβ expression (ESR1, based on mRNA levels) was correlated with a shorter 1-year disease-specific survival (p = 0.05), suggesting that ERβ may be a marker of poor biological behavior in EAC [24]. Here, ESR2 is linked to neoplasm.